Infinitus began with a prankish test call, a hang-up, and one stubborn second attempt. Seven years later, its AI agents are doing the dull, consequential work between a prescription and the patient who needs it.
A medicine’s success can bury its maker in safety reports. Qinecsa has bought and built a business around getting those reports into useful shape - and giving specialists more time to read the warning signs.